Your browser doesn't support javascript.
loading
Genome-wide Study Identifies Association between HLA-B55:01 and Self-Reported Penicillin Allergy.
Krebs, Kristi; Bovijn, Jonas; Zheng, Neil; Lepamets, Maarja; Censin, Jenny C; Jürgenson, Tuuli; Särg, Dage; Abner, Erik; Laisk, Triin; Luo, Yang; Skotte, Line; Geller, Frank; Feenstra, Bjarke; Wang, Wei; Auton, Adam; Raychaudhuri, Soumya; Esko, Tõnu; Metspalu, Andres; Laur, Sven; Roden, Dan M; Wei, Wei-Qi; Holmes, Michael V; Lindgren, Cecilia M; Phillips, Elizabeth J; Mägi, Reedik; Milani, Lili; Fadista, João.
Afiliação
  • Krebs K; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia; Institute of Molecular and Cell Biology, University of Tartu, Tartu 51010, Estonia.
  • Bovijn J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7FZ, UK.
  • Zheng N; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Lepamets M; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia; Institute of Molecular and Cell Biology, University of Tartu, Tartu 51010, Estonia.
  • Censin JC; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7FZ, UK.
  • Jürgenson T; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia.
  • Särg D; Institute of Computer Science, University of Tartu, Tartu 51009, Estonia.
  • Abner E; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia.
  • Laisk T; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia.
  • Luo Y; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Departmen
  • Skotte L; Department of Epidemiology Research, Statens Serum Institut, Copenhagen 2300, Denmark.
  • Geller F; Department of Epidemiology Research, Statens Serum Institut, Copenhagen 2300, Denmark.
  • Feenstra B; Department of Epidemiology Research, Statens Serum Institut, Copenhagen 2300, Denmark.
  • Wang W; 23andMe, Inc., Sunnyvale, CA 94086, USA.
  • Auton A; 23andMe, Inc., Sunnyvale, CA 94086, USA.
  • Raychaudhuri S; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Departmen
  • Esko T; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia.
  • Metspalu A; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia.
  • Laur S; Institute of Computer Science, University of Tartu, Tartu 51009, Estonia; STACC, Tartu 51009, Estonia.
  • Roden DM; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pharmacology, Vanderbilt University School of Medicine, TN 37232, USA.
  • Wei WQ; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Holmes MV; Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7FZ, UK; National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford OX3 7LE, UK; Clinic
  • Lindgren CM; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford OX3 7FZ, UK; National Institute for Health Research Oxford Biomedical Researc
  • Phillips EJ; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pharmacology, Vanderbilt University School of Medicine, TN 37232, USA; Institute for Immunology & Infectious Diseases, Murdoch University, Murdoch, WA 6150, Australia.
  • Mägi R; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia.
  • Milani L; Estonian Genome Center, Institute of Genomics, University of Tartu, Tartu 51010, Estonia. Electronic address: lili.milani@ut.ee.
  • Fadista J; Department of Epidemiology Research, Statens Serum Institut, Copenhagen 2300, Denmark; Department of Clinical Sciences, Lund University Diabetes Centre, 214 28 Malmö, Sweden; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki 00014, Finland.
Am J Hum Genet ; 107(4): 612-621, 2020 10 01.
Article em En | MEDLINE | ID: mdl-32888428
ABSTRACT
Hypersensitivity reactions to drugs are often unpredictable and can be life threatening, underscoring a need for understanding their underlying mechanisms and risk factors. The extent to which germline genetic variation influences the risk of commonly reported drug allergies such as penicillin allergy remains largely unknown. We extracted data from the electronic health records of more than 600,000 participants from the UK, Estonian, and Vanderbilt University Medical Center's BioVU biobanks to study the role of genetic variation in the occurrence of self-reported penicillin hypersensitivity reactions. We used imputed SNP to HLA typing data from these cohorts to further fine map the human leukocyte antigen (HLA) association and replicated our results in 23andMe's research cohort involving a total of 1.12 million individuals. Genome-wide meta-analysis of penicillin allergy revealed two loci, including one located in the HLA region on chromosome 6. This signal was further fine-mapped to the HLA-B∗5501 allele (OR 1.41 95% CI 1.33-1.49, p value 2.04 × 10-31) and confirmed by independent replication in 23andMe's research cohort (OR 1.30 95% CI 1.25-1.34, p value 1.00 × 10-47). The lead SNP was also associated with lower lymphocyte counts and in silico follow-up suggests a potential effect on T-lymphocytes at HLA-B∗5501. We also observed a significant hit in PTPN22 and the GWAS results correlated with the genetics of rheumatoid arthritis and psoriasis. We present robust evidence for the role of an allele of the major histocompatibility complex (MHC) I gene HLA-B in the occurrence of penicillin allergy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Psoríase / Antígenos HLA-B / Polimorfismo de Nucleotídeo Único / Hipersensibilidade a Drogas / Proteína Tirosina Fosfatase não Receptora Tipo 22 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte / Europa Idioma: En Revista: Am J Hum Genet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estônia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Psoríase / Antígenos HLA-B / Polimorfismo de Nucleotídeo Único / Hipersensibilidade a Drogas / Proteína Tirosina Fosfatase não Receptora Tipo 22 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte / Europa Idioma: En Revista: Am J Hum Genet Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estônia